Notes from the Field: Nationwide Hepatitis E Outbreak Concentrated in Informal Settlements — Namibia, 2017–2020

Nirma D. Bustamante, MD1; Selma Robert Matyenyika2; Leigh Ann Miller, PhD3; Matthew Goers, MD1; Puumue Katjiuanjo, MPH, MSc2; Kakehongo Ndiitodino, MSc2; Emmy-Else Ndevaetela, MPH2; Undjee Kaura2; Kofi Mensah Nyarko, MD2; Lilliane Kahuika-Crentsil, MD2; Bernard Haufiku, MD2; Thomas Handzel, PhD1; Eyasu H. Teshale, MD4; Eric J. Dziuban, MD3; Benetus T. Nangombe3; Megan G. Hofmeister, MD4 (View author affiliations)

View suggested citation
Article Metrics
Altmetric:
Citations:
Views:

Views equals page views plus PDF downloads

Related Materials

In September 2017, Namibia’s Ministry of Health and Social Services (MoHSS) identified an increase in cases of acute jaundice in Khomas region, which includes the capital city of Windhoek. Hepatitis E is a liver disease caused by hepatitis E virus, which is transmitted by the fecal-oral route, causing symptoms consistent with acute jaundice syndrome (1). Hepatitis E is rarely fatal; however, the disease can be severe in pregnant women, resulting in fulminant hepatic failure and death (2).

On December 14, 2017, MoHSS declared a hepatitis E outbreak in Khomas, which subsequently developed into a nationwide protracted epidemic, centered mainly in informal settlements with poor sanitary conditions. During December 14, 2017–February 2, 2020, a total of 7,247 outbreak-associated hepatitis E cases were reported (Figure). Data on cases were obtained through epidemiologic surveillance, active case finding, and review of health care facility records. Cases were categorized as 1) suspected (acute onset of jaundice or dark urine and pale stools preceded by acute “flu-like” illness and at least one of the following: low grade fever (100.4°F–102.2°F[38°C–39°C]), anorexia, fatigue, nausea or vomiting); 2) epidemiologically linked (suspected case in a person with recent travel to a known outbreak-affected region), or 3) confirmed (acute jaundice with detection of hepatitis E virus immunoglobulin M antibody in serum). Among reported cases, 925 (13%) were suspected, 4,500 (63%) were epidemiologically linked, and 1,822 (24%) were confirmed. All of Namibia’s 14 regions have now detected hepatitis E cases. The majority of cases (59%) occurred in males, and 72% of cases were in persons aged 20–39 years. Sixty-one deaths (0.8%) were reported nationally, including 24 (39%) in pregnant or postpartum women (maternal case fatality rate = 6%). Among all reported cases, 6,068 (84%) were reported from Khomas and Erongo regions, which have large informal settlements. Specifically, 2,677 (37%) cases were reported from three of Namibia’s largest informal settlements, Havana and Goreangab (both in Khomas region), and the Democratic Resettlement Community (in Erongo region). Because of increased rural-urban migration, many low-income workers live in informal settlements with substandard housing and poor sanitation.

CDC has provided technical assistance since the beginning of the outbreak through its Namibia country office. An expanded CDC team was invited to support the national epidemiologic efforts in October 2018. During this response, CDC and international partners helped MoHSS strengthen its surveillance system and data management processes. Activities included standardization of line lists and variables, enhancement of disease-specific surveillance through four national training sessions (totaling 54 staff members), development of effective communication strategies through a reformatted situation report, and supporting implementation of effective outbreak control and prevention measures.

This is the third hepatitis E outbreak described in Namibia since 1983, the largest to date, and the first of nationwide scope (3,4). The government of Namibia estimates that approximately 40% of households in urban areas are in informal settlements with minimal infrastructure, limited access to latrines and piped water, and poor hygiene (5). Although the national population growth rate has been approximately 1.4% per year, in informal settlements the growth rate has been 8%–15% per year (6). Improved hand hygiene and sanitation practices and access to safe water are needed to interrupt the transmission of hepatitis E virus in this protracted national outbreak, especially given the high risk of mortality to pregnant women. In Namibia, there are efforts in most affected areas to improve access to and use of latrines through Community-Led Total Sanitation* to address the outbreak.

Corresponding author: Nirma D. Bustamante, okl6@cdc.gov, 404-498-5958.


1Division of Global Health Protection, Center for Global Health, CDC; 2Ministry of Health and Social Services, Namibia; 3Division of Global HIV & TB, Center for Global Health, CDC; 4Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC.

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.


References

  1. Gerbi GB, Williams R, Bakamutumaho B, et al. Hepatitis E as a cause of acute jaundice syndrome in northern Uganda, 2010–2012. Am J Trop Med Hyg 2015;92:411–4. CrossRefexternal icon PubMedexternal icon
  2. CDC. Hepatitis E questions and answers for health professionals. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https://www.cdc.gov/hepatitis/hev/hevfaq.htm#section1
  3. Isaäcson M, Frean J, He J, Seriwatana J, Innis BL. An outbreak of hepatitis E in Northern Namibia, 1983. Am J Trop Med Hyg 2000;62:619–25. CrossRefexternal icon
  4. Maila HT, Bowyer SM, Swanepoel R. Identification of a new strain of hepatitis E virus from an outbreak in Namibia in 1995. J Gen Virol 2004;85:89–95. CrossRefexternal icon
  5. Namibia Ministry of Justice. Responses on the questionnaire of informal settlements and human rights. Windhoek, Namibia: Namibia Ministry of Justice; 2017. https://www.ohchr.org/Documents/Issues/Housing/InformalSettlements/Namibia.pdfpdf iconexternal icon
  6. Development workshop–Namibia. Informal settlement of Namibia: provision of affordable land to the urban poor. Windhoek, Namibia: Development Workshop–Namibia; 2017. http://dw-namibia.org/pagetitle1/external icon
Return to your place in the textFIGURE. Number of hepatitis E cases (N = 7,247), by week of case detection and region of country* — Namibia, 2017–2020
The figure is a histogram, an epidemiologic curve showing the number of cases of hepatitis E (N = 7,247), by week of case detection and region of country in Namibia during 2017–2020.

* Khomas and Erongo regions have large informal settlements and have accounted for 6,068 (84%) of the hepatitis E cases.


Suggested citation for this article: Bustamante ND, Matyenyika SR, Miller LA, et al. Notes from the Field: Nationwide Hepatitis E Outbreak Concentrated in Informal Settlements — Namibia, 2017–2020. MMWR Morb Mortal Wkly Rep 2020;69:355–357. DOI: http://dx.doi.org/10.15585/mmwr.mm6912a6external icon.

MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

View Page In:pdf icon PDF [118K]
Page last reviewed: March 26, 2020